New data shows Alzheimer's drug can benefit some patients
04:58
Share this -
copied
Dr. Madhav Thambisetty of Johns Hopkins School of Medicine joins Morning Joe to discus the results of a clinical trial of an experimental Alzheimer’s drug that suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease.Nov. 30, 2022
UP NEXT
United States sending 31 Abrams tanks to Ukraine
08:30
Morning Joe: Special Report from Auschwitz
36:39
How the Auschwitz Jewish Center honors the past
07:25
Richard Haass on the importance of putting country before party
08:40
Rep. Schiff: I'm deeply concerned with Speaker McCarthy's actions
06:33
'It's as real as it gets': Second Gentleman marks Holocaust Remembrance Day